Sign Up
OverviewAPI
Owkin, a French-American biotech company, has partnered with MSD (Merck & Co Inc) to develop AI-based cancer diagnostics, focusing on MSI-H in colorectal cancer and expanding to other cancer types. The collaboration aims to improve diagnostic accuracy, reduce screening time, and minimize costs, leveraging Owkin's AI platform for enhanced diagnostic capabilities.

Ask a question